Robotic Surgery Company Memic Rebrands as Momentis

The new identity comes shortly after the company nixed a special purpose acquisition corporation (SPAC) merger.

Amanda Pedersen

July 5, 2022

3 Min Read
Momentis Surgical (formerly known as Memic) CEO Dvir Cohen talking about the company's new identity.

Sometimes as a company grows and matures, the corporate identity it started out with no longer fits. A Tel Aviv, Israel-based robotic surgery company is one such example.

Formerly known as Memic Innovative Surgery, the company has rebranded to become Momentis Surgical. The company also changed the name of its technology from Hominis Surgical System to Anovo Surgical System. The rebranding was unveiled last Friday during the annual meeting of the Society of Robotic and Digital Surgery (SRS 2022) in Lake Buena Vista, FL.

“We are pleased to announce our new identity as Momentis Surgical. As an innovative and visionary technology company, we want to ensure that our brand aligns with our vision and core values and reflects our expanded corporate mission to transform the field of robotic surgery in a range of indications using next-generation surgical robots that provide a human touch, mirroring the movements of the human body to enable surgeons to perform procedures previously unimaginable,” said Dvir Cohen, CEO of Momentis. “We believe the name Momentis captures not only where we find ourselves as a company today, but it reflects our inspiration for future growth as an organization.”

The rebranding also comes just a few months after the robotic surgery company nixed a special purpose acquisition corporation (SPAC) merger with Medtech Acquisition Corps, a mutual decision based on market conditions and recent world events.

At SRS 2022, the robotic surgery company also highlighted clinical data of the Anovo System in seven presentations including four oral presentations. In one of the oral presentations, titled “Advancements in Robotic Gynecology: Vaginal Robotics,” Ricardo E. Estape, MD, a gynecologic surgeon and director of the HCA Florida Institute for Gynecologic Oncology at Kendall Hospital, and Erica Stockwell, a gynecologic surgeon at Celebration, FL-based AdventHealth Celebration, reviewed the history of robotic surgery and the clinical benefits of the transvaginal approach to gynecological surgery.

Estape also discussed his clinical experience with the Anovo System (pictured below), as the first surgeon in the U.S. to ever perform a robotic-assisted transvaginal hysterectomy using this technology. He has performed six patient procedures to-date, all completed with good results and all patients were discharged from the hospital same day post-surgery.

Photo of the Anovo Surgical System, formerly known as the Hominis System, used for robotic surgery

The Anovo System is indicated for use in robotic-assisted transvaginal benign surgical procedures including benign hysterectomy, salpingectomy, oophorectomy, adnexectomy, and ovarian cyst removal. Multiple instruments can be introduced to the body through a single portal and the unprecedented articulation of the robotic arms offers optimal access and working angles. Anovo requires a much smaller footprint and costs significantly less than conventional robotic systems, making it possible for more hospitals and ambulatory surgery centers to acquire the system and offer more patients the benefits of less invasive robotic surgery.

In June, Momentis announced the first U.S. patient procedures were successfully performed using the Anovo System for robotic-assisted transvaginal hysterectomy at HCA Florida Kendall Hospital and The Women’s Hospital at Jackson Memorial.

About the Author(s)

Amanda Pedersen

Amanda Pedersen is a veteran journalist and award-winning columnist with a passion for helping medical device professionals connect the dots between the medtech news of the day and the bigger picture. She has been covering the medtech industry since 2006.

Sign up for the QMED & MD+DI Daily newsletter.

You May Also Like